ArticlePoultry science2026
Effects of chitosan-nanoparticles on hematological indices, renal and liver function, lipid metabolism, abdominal adipose deposition, carcass traits, and growth performance of broiler chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Paeonol-Loaded Cyclodextrin/Composite Hydrogel for Enhanced Transdermal Delivery and Skin Photoaging Repair.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated chitosan nanoparticles (ChNPs) as a feed additive for broilers. A total of 400 d-old male Ross 308 broilers were randomly allocated into four treatments with five replication pens, each pen had 20 broilers. The experimental diets were as follows: First group was fed a basal diet only (control); 2nd, 3rd, and 4th groups received a basal diet supplemented with 50 (ChNPs-50), 100 (ChNPs-100), and 150 (ChNPs-150) mg ChNPs /kg of feed, respectively. Results showed that dietary supplementation with ChNPs reduced mortality and feed conversion ratio, while weight gain and feed intake showed non-significant trends toward improvement. Abdominal fat decreased significantly, whereas breast weight increased, with the highest values in the 100 and 150 mg/kg groups. Dressing percentage improved significantly, while liver weight remained unaffected. Linear trends confirmed dose-dependent improvements in abdominal fat, breast yield, and dressing percentage. Regarding liver function, ChNPs significantly reduced alanine aminotransferase activity. In renal function, creatinine decreased significantly in the highest ChNPs group, while uric acid and urea showed non-significant declines. ChNPs markedly improved lipid profiles. Low-density lipoprotein and total cholesterol decreased significantly, while high-density lipoprotein increased in the 150 mg/kg group. Triglycerides also declined significantly at the highest supplementation. Linear effects for all lipid parameters indicated dose-dependent improvements. Heterophils decreased and lymphocytes increased in ChNPs-supplemented birds, resulting in a significantly lower HET/LYM ratio. Overall, dietary ChNPs supplementation enhanced growth performance, carcass quality, liver and kidney function, lipid metabolism, and immune cell distribution in broilers, with dose-dependent effects evident across multiple physiological and biochemical parameters.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.